CCA
HZNP

Canyon Capital Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Canyon Capital Advisors’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-500,000
Closed -$57.8M – 29
2023
Q3 		$57.8M Buy
500,000
+250,000
+100% +$28.9M 5.71% 6
2023
Q2 		$25.7M Buy
+250,000
New +$25.7M 2.54% 10